Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,679 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lopinavir/ritonavir pharmacokinetics in HIV and hepatitis C virus co-infected patients without liver function impairment: influence of liver fibrosis.
Moltó J, Valle M, Blanco A, Negredo E, DelaVarga M, Miranda C, Miranda J, Domingo P, Vilaró J, Tural C, Costa J, Barbanoj MJ, Clotet B. Moltó J, et al. Among authors: miranda j, miranda c. Clin Pharmacokinet. 2007;46(1):85-92. doi: 10.2165/00003088-200746010-00005. Clin Pharmacokinet. 2007. PMID: 17201460
Variability in non-nucleoside reverse transcriptase and protease inhibitors concentrations among HIV-infected adults in routine clinical practice.
Moltó J, Blanco A, Miranda C, Miranda J, Puig J, Valle M, Delavarga M, Fumaz CR, Barbanoj MJ, Clotet B. Moltó J, et al. Among authors: miranda j, miranda c. Br J Clin Pharmacol. 2007 Jun;63(6):715-21. doi: 10.1111/j.1365-2125.2006.02834.x. Epub 2007 Jan 12. Br J Clin Pharmacol. 2007. PMID: 17223856 Free PMC article.
Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART.
Bonjoch A, Paredes R, Galvez J, Miralles C, Videla S, Martínez E, Miranda J, Muñoz-Moreno JA, De la Torre J, Prieto A, Vilades C, Clotet B; SimplifiHAART Study Group. Bonjoch A, et al. Among authors: miranda j. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):313-6. doi: 10.1097/01.qai.0000164249.33851.3a. J Acquir Immune Defic Syndr. 2005. PMID: 15980691 Clinical Trial.
Protease inhibitor resistance analysis in the MONARK trial comparing first-line lopinavir-ritonavir monotherapy to lopinavir-ritonavir plus zidovudine and lamivudine triple therapy.
Delaugerre C, Flandre P, Chaix ML, Ghosn J, Raffi F, Dellamonica P, Jaeger H, Shürmann D, Cohen-Codar I, Van PN, Norton M, Taburet AM, Delfraissy JF, Rouzioux C; MONARK Study Group. Delaugerre C, et al. Antimicrob Agents Chemother. 2009 Jul;53(7):2934-9. doi: 10.1128/AAC.01643-08. Epub 2009 May 18. Antimicrob Agents Chemother. 2009. PMID: 19451297 Free PMC article. Clinical Trial.
Collective motion of energy depot active disks.
Miranda JP, Levis D, Valeriani C. Miranda JP, et al. Soft Matter. 2024 Nov 27. doi: 10.1039/d4sm00785a. Online ahead of print. Soft Matter. 2024. PMID: 39600192
2,679 results